T1396 Randomized Controlled Trial of the Selective Serotonin Reuptake Inhibitor (SSRI) Citalopram (CIT) vs. Placebo (PLC) in Non-Depressed Patients with Irritable Bowel Syndrome (IBS).

Gastroenterology

Uri Ladabaum, Annie Sharabidze, Theodore R. Levin, Wei K. Zhao, Elaine H. Chung, Peter Bacchetti, Chengshi Jin, Barbara A. Grimes, Craig J. Pepin. T1396 Randomized Controlled Trial of the Selective Serotonin Reuptake Inhibitor (SSRI) Citalopram (CIT) vs. Placebo (PLC) in Non-Depressed Patients with Irritable Bowel Syndrome (IBS). Gastroenterology. 2008 Apr 1; 134(4):a-546.

2008

https://researcherprofiles.org/profile/79296605

Uri Ladabaum, Annie Sharabidze, Theodore R. Levin, Wei K. Zhao, Elaine H. Chung, Peter Bacchetti, Chengshi Jin, Barbara A. Grimes, Craig J. Pepin

Transplant Outcomes Research Center

Search form

You are here

T1396 Randomized Controlled Trial of the Selective Serotonin Reuptake Inhibitor (SSRI) Citalopram (CIT) vs. Placebo (PLC) in Non-Depressed Patients with Irritable Bowel Syndrome (IBS).